Atlas Trials

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML

Clinical trial NCT01496547 · COMPLETED

Trial details

NCT number
NCT01496547
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Leukemia
Start date
2011-01-01
Primary completion
2018-02-28
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.